Michael Smith

The AMA is warning that Australia is at risk of adopting “US-style managed care” where insurance companies call all the shots.

A finger-lickin’ good bucket of fried chicken and strawberry shortcake were not what our former foreign correspondent was counting on.

The value of West Australian nerve repair biotech Orthocell has doubled since September as it beefs up its shareholder bases and prepares to break into the US.

A surge in young people taking up private health cover drove membership to a record high in the September quarter, despite a cost-of-living crisis.

Private health insurers are being derided all around, but their chief lobbyist, Rachel David, insists they make our medical system the envy of the Americans and British.

Christian Behrenbruch, the founder of ASX biotech giant Telix, says Australia has a “horrible” track record getting drugs to patients and lags rest of the world.

Health Minister Mark Butler says insurers seeking premium increases may be asked to “sharpen their pencils” as cost-of-living pressures bite.

Chief executive Mick Farrell says the company has only scratched the service in global demand for sleeping disorder devices.

The cancer treatment giant wants to sell shares to investors and staff in North America as it eyes growth in the region.

Australia’s top nuclear physicians say their patients will die earlier and in more pain if they are forced to stop making more affordable alternatives.